NCT05404789View on ClinicalTrials.gov

Tolerance of Centrifuge-induced Acceleration in Subjects With Diabetes Mellitus and Cardiac Arrhythmia

NACompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

September 27, 2021

Primary Completion Date

October 1, 2022

Study Completion Date

October 1, 2022

Conditions
Diabetes MellitusArrhythmias, Cardiac
Interventions
OTHER

Centrifugation

Subjects will participate in up to seven different centrifuge profiles over a single day of training (approximately 8 hours). Exposures are design to simulate a spaceflight profile using acceleration anticipated for commercial spaceflights.

Trial Locations (1)

77555-1110

University of Texas Medical Branch, Galveston

All Listed Sponsors
collaborator

Civil Aerospace Medical Institute

FED

lead

The University of Texas Medical Branch, Galveston

OTHER

NCT05404789 - Tolerance of Centrifuge-induced Acceleration in Subjects With Diabetes Mellitus and Cardiac Arrhythmia | Biotech Hunter | Biotech Hunter